Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001308696 | SCV001498159 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2022-08-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003294247 | SCV003999983 | uncertain significance | Cardiovascular phenotype | 2023-03-25 | criteria provided, single submitter | clinical testing | The p.I918V variant (also known as c.2752A>G), located in coding exon 23 of the JAG1 gene, results from an A to G substitution at nucleotide position 2752. The isoleucine at codon 918 is replaced by valine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |